Citation Tools

Download PDFPDF

Original research
Clinical outcomes of prexasertib monotherapy in recurrent BRCA wild-type high-grade serous ovarian cancer involve innate and adaptive immune responses

Download to a citation manager

Cite this article as:
Lampert EJ, Cimino-Mathews A, Lee JS, et al
Clinical outcomes of prexasertib monotherapy in recurrent BRCA wild-type high-grade serous ovarian cancer involve innate and adaptive immune responses